X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   MYLAN
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
MYLAN
Dec-14
JUBILANT LIFE SCIENCES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1874,042-   
Low Rs652,848-   
Sales per share (Unadj.) Rs364.31,383.8-  
Earnings per share (Unadj.) Rs6.8166.7-  
Cash flow per share (Unadj.) Rs24.5268.3-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.9687.9-  
Shares outstanding (eoy) m159.28378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x0.32.5 13.9%   
Avg P/E ratio x18.420.7 89.0%  
P/CF ratio (eoy) x5.112.8 40.0%  
Price / Book Value ratio x0.85.0 15.2%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,0611,303,581 1.5%   
No. of employees `0006.225.0 24.7%   
Total wages/salary Rs m11,0520-   
Avg. sales/employee Rs Th9,383.020,942.8 44.8%   
Avg. wages/employee Rs Th1,786.90-   
Avg. net profit/employee Rs Th176.32,522.9 7.0%   
INCOME DATA
Net Sales Rs m58,034523,570 11.1%  
Other income Rs m191-3,052 -6.2%   
Total revenues Rs m58,224520,519 11.2%   
Gross profit Rs m5,786130,214 4.4%  
Depreciation Rs m2,81238,454 7.3%   
Interest Rs m3,23722,584 14.3%   
Profit before tax Rs m-7266,125 -0.1%   
Minority Interest Rs m-286-271 105.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m6962,781 25.0%   
Profit after tax Rs m1,09063,073 1.7%  
Gross profit margin %10.024.9 40.1%  
Effective tax rate %-965.94.2 -22,969.1%   
Net profit margin %1.912.0 15.6%  
BALANCE SHEET DATA
Current assets Rs m29,280460,288 6.4%   
Current liabilities Rs m38,912359,853 10.8%   
Net working cap to sales %-16.619.2 -86.5%  
Current ratio x0.81.3 58.8%  
Inventory Days Days8478 108.1%  
Debtors Days Days51107 47.2%  
Net fixed assets Rs m55,712121,127 46.0%   
Share capital Rs m15518,515 0.8%   
"Free" reserves Rs m20,9680-   
Net worth Rs m26,265260,266 10.1%   
Long term debt Rs m17,169388,812 4.4%   
Total assets Rs m88,6061,048,328 8.5%  
Interest coverage x1.03.9 24.9%   
Debt to equity ratio x0.71.5 43.8%  
Sales to assets ratio x0.70.5 131.1%   
Return on assets %4.98.2 59.8%  
Return on equity %4.224.2 17.1%  
Return on capital %11.613.6 84.9%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Net fx Rs m10,2550-   
CASH FLOW
From Operations Rs m8,02668,824 11.7%  
From Investments Rs m-1,744-54,276 3.2%  
From Financial Activity Rs m-4,447-18,135 24.5%  
Net Cashflow Rs m1,834-3,588 -51.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 67.82 Rs / USD

Compare JUBILANT LIFE SCIENCES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare JUBILANT LIFE SCIENCES With: VENUS REMEDIES  DR. REDDYS LAB  PIRAMAL ENTERPRISES  SUVEN LIFE  DR. DATSONS LABS  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jun 22, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS